We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry Canada NewsWire BERLIN, Sept. 4, 2019 New investments will...
/R E P E A T -- Chinook Announces Name Change to AMP German Cannabis Group and Listing on the Canadian Securities Exchange/ Canada NewsWire BERLIN, Aug. 22, 2019 BERLIN, Aug. 22, 2019 /CNW/...
Chinook Announces Name Change to AMP German Cannabis Group and Listing on the Canadian Securities Exchange Canada NewsWire BERLIN, Aug. 22, 2019 BERLIN, Aug. 22, 2019 /CNW/ - Chinook Tyee...
/R E P E A T -- Chinook Closes $1.5 Million Canadian Dollar Series A Private Placement/ Canada NewsWire BERLIN, June 12, 2019 Chinook Insiders are the largest investors in the Series A financing...
Chinook Closes $1.5 Million Canadian Dollar Series A Private Placement Canada NewsWire BERLIN, June 12, 2019 Chinook Insiders are the largest investors in the Series A financing as its German...
Chinook joins forces with a leading German pharmaceutical consulting company Canada NewsWire BERLIN, Germany, May 29, 2019 Chinook establishes EU-GMP standards for its imports of medical cannabis...
Chinook's subsidiary, AMP Alternative Medical Products, enters into a memorandum of understanding with Pure Life Cannabis for export to Germany Canada NewsWire ERFURT, Germany and EDMONTON...
Update on Chinook's Investments in Germany Canada NewsWire BERLIN, Feb. 5, 2019 BERLIN, Feb. 5, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) is an investment...
Chinook subsidiary, AMP Alternative Medical Products, receives €500,000 Series B financing to fund its medical cannabis business in Germany Canada NewsWire ERFURT, Germany, Dec. 3, 2018...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions